ArticleJournal of translational medicine2013

Phase 1 studies of the safety and immunogenicity of electroporated HER2/CEA DNA vaccine followed by adenoviral boost immunization in patients with solid tumors.

Claudia Marcela Diaz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.